Cargando…
HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
Systemic sclerosis (SSc) is a clinically heterogeneous autoimmune disease characterized by mutually exclusive autoantibodies directed against distinct nuclear antigens. We examined HLA associations in SSc and its autoantibody subsets in a large, newly recruited African American (AA) cohort and among...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955366/ https://www.ncbi.nlm.nih.gov/pubmed/31871193 http://dx.doi.org/10.1073/pnas.1906593116 |
_version_ | 1783486924169674752 |
---|---|
author | Gourh, Pravitt Safran, Sarah A. Alexander, Theresa Boyden, Steven E. Morgan, Nadia D. Shah, Ami A. Mayes, Maureen D. Doumatey, Ayo Bentley, Amy R. Shriner, Daniel Domsic, Robyn T. Medsger, Thomas A. Ramos, Paula S. Silver, Richard M. Steen, Virginia D. Varga, John Hsu, Vivien Saketkoo, Lesley Ann Schiopu, Elena Khanna, Dinesh Gordon, Jessica K. Kron, Brynn Criswell, Lindsey A. Gladue, Heather Derk, Chris T. Bernstein, Elana J. Bridges, S. Louis Shanmugam, Victoria K. Kolstad, Kathleen D. Chung, Lorinda Kafaja, Suzanne Jan, Reem Trojanowski, Marcin Goldberg, Avram Korman, Benjamin D. Steinbach, Peter J. Chandrasekharappa, Settara C. Mullikin, James C. Adeyemo, Adebowale Rotimi, Charles Wigley, Fredrick M. Kastner, Daniel L. Boin, Francesco Remmers, Elaine F. |
author_facet | Gourh, Pravitt Safran, Sarah A. Alexander, Theresa Boyden, Steven E. Morgan, Nadia D. Shah, Ami A. Mayes, Maureen D. Doumatey, Ayo Bentley, Amy R. Shriner, Daniel Domsic, Robyn T. Medsger, Thomas A. Ramos, Paula S. Silver, Richard M. Steen, Virginia D. Varga, John Hsu, Vivien Saketkoo, Lesley Ann Schiopu, Elena Khanna, Dinesh Gordon, Jessica K. Kron, Brynn Criswell, Lindsey A. Gladue, Heather Derk, Chris T. Bernstein, Elana J. Bridges, S. Louis Shanmugam, Victoria K. Kolstad, Kathleen D. Chung, Lorinda Kafaja, Suzanne Jan, Reem Trojanowski, Marcin Goldberg, Avram Korman, Benjamin D. Steinbach, Peter J. Chandrasekharappa, Settara C. Mullikin, James C. Adeyemo, Adebowale Rotimi, Charles Wigley, Fredrick M. Kastner, Daniel L. Boin, Francesco Remmers, Elaine F. |
author_sort | Gourh, Pravitt |
collection | PubMed |
description | Systemic sclerosis (SSc) is a clinically heterogeneous autoimmune disease characterized by mutually exclusive autoantibodies directed against distinct nuclear antigens. We examined HLA associations in SSc and its autoantibody subsets in a large, newly recruited African American (AA) cohort and among European Americans (EA). In the AA population, the African ancestry-predominant HLA-DRB1*08:04 and HLA-DRB1*11:02 alleles were associated with overall SSc risk, and the HLA-DRB1*08:04 allele was strongly associated with the severe antifibrillarin (AFA) antibody subset of SSc (odds ratio = 7.4). These African ancestry-predominant alleles may help explain the increased frequency and severity of SSc among the AA population. In the EA population, the HLA-DPB1*13:01 and HLA-DRB1*07:01 alleles were more strongly associated with antitopoisomerase (ATA) and anticentromere antibody-positive subsets of SSc, respectively, than with overall SSc risk, emphasizing the importance of HLA in defining autoantibody subtypes. The association of the HLA-DPB1*13:01 allele with the ATA(+) subset of SSc in both AA and EA patients demonstrated a transancestry effect. A direct correlation between SSc prevalence and HLA-DPB1*13:01 allele frequency in multiple populations was observed (r = 0.98, P = 3 × 10(−6)). Conditional analysis in the autoantibody subsets of SSc revealed several associated amino acid residues, mostly in the peptide-binding groove of the class II HLA molecules. Using HLA [Formula: see text] / [Formula: see text] allelic heterodimers, we bioinformatically predicted immunodominant peptides of topoisomerase 1, fibrillarin, and centromere protein A and discovered that they are homologous to viral protein sequences from the Mimiviridae and Phycodnaviridae families. Taken together, these data suggest a possible link between HLA alleles, autoantibodies, and environmental triggers in the pathogenesis of SSc. |
format | Online Article Text |
id | pubmed-6955366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-69553662020-01-14 HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry Gourh, Pravitt Safran, Sarah A. Alexander, Theresa Boyden, Steven E. Morgan, Nadia D. Shah, Ami A. Mayes, Maureen D. Doumatey, Ayo Bentley, Amy R. Shriner, Daniel Domsic, Robyn T. Medsger, Thomas A. Ramos, Paula S. Silver, Richard M. Steen, Virginia D. Varga, John Hsu, Vivien Saketkoo, Lesley Ann Schiopu, Elena Khanna, Dinesh Gordon, Jessica K. Kron, Brynn Criswell, Lindsey A. Gladue, Heather Derk, Chris T. Bernstein, Elana J. Bridges, S. Louis Shanmugam, Victoria K. Kolstad, Kathleen D. Chung, Lorinda Kafaja, Suzanne Jan, Reem Trojanowski, Marcin Goldberg, Avram Korman, Benjamin D. Steinbach, Peter J. Chandrasekharappa, Settara C. Mullikin, James C. Adeyemo, Adebowale Rotimi, Charles Wigley, Fredrick M. Kastner, Daniel L. Boin, Francesco Remmers, Elaine F. Proc Natl Acad Sci U S A Biological Sciences Systemic sclerosis (SSc) is a clinically heterogeneous autoimmune disease characterized by mutually exclusive autoantibodies directed against distinct nuclear antigens. We examined HLA associations in SSc and its autoantibody subsets in a large, newly recruited African American (AA) cohort and among European Americans (EA). In the AA population, the African ancestry-predominant HLA-DRB1*08:04 and HLA-DRB1*11:02 alleles were associated with overall SSc risk, and the HLA-DRB1*08:04 allele was strongly associated with the severe antifibrillarin (AFA) antibody subset of SSc (odds ratio = 7.4). These African ancestry-predominant alleles may help explain the increased frequency and severity of SSc among the AA population. In the EA population, the HLA-DPB1*13:01 and HLA-DRB1*07:01 alleles were more strongly associated with antitopoisomerase (ATA) and anticentromere antibody-positive subsets of SSc, respectively, than with overall SSc risk, emphasizing the importance of HLA in defining autoantibody subtypes. The association of the HLA-DPB1*13:01 allele with the ATA(+) subset of SSc in both AA and EA patients demonstrated a transancestry effect. A direct correlation between SSc prevalence and HLA-DPB1*13:01 allele frequency in multiple populations was observed (r = 0.98, P = 3 × 10(−6)). Conditional analysis in the autoantibody subsets of SSc revealed several associated amino acid residues, mostly in the peptide-binding groove of the class II HLA molecules. Using HLA [Formula: see text] / [Formula: see text] allelic heterodimers, we bioinformatically predicted immunodominant peptides of topoisomerase 1, fibrillarin, and centromere protein A and discovered that they are homologous to viral protein sequences from the Mimiviridae and Phycodnaviridae families. Taken together, these data suggest a possible link between HLA alleles, autoantibodies, and environmental triggers in the pathogenesis of SSc. National Academy of Sciences 2020-01-07 2019-12-23 /pmc/articles/PMC6955366/ /pubmed/31871193 http://dx.doi.org/10.1073/pnas.1906593116 Text en Copyright © 2020 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/ https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Biological Sciences Gourh, Pravitt Safran, Sarah A. Alexander, Theresa Boyden, Steven E. Morgan, Nadia D. Shah, Ami A. Mayes, Maureen D. Doumatey, Ayo Bentley, Amy R. Shriner, Daniel Domsic, Robyn T. Medsger, Thomas A. Ramos, Paula S. Silver, Richard M. Steen, Virginia D. Varga, John Hsu, Vivien Saketkoo, Lesley Ann Schiopu, Elena Khanna, Dinesh Gordon, Jessica K. Kron, Brynn Criswell, Lindsey A. Gladue, Heather Derk, Chris T. Bernstein, Elana J. Bridges, S. Louis Shanmugam, Victoria K. Kolstad, Kathleen D. Chung, Lorinda Kafaja, Suzanne Jan, Reem Trojanowski, Marcin Goldberg, Avram Korman, Benjamin D. Steinbach, Peter J. Chandrasekharappa, Settara C. Mullikin, James C. Adeyemo, Adebowale Rotimi, Charles Wigley, Fredrick M. Kastner, Daniel L. Boin, Francesco Remmers, Elaine F. HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry |
title | HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry |
title_full | HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry |
title_fullStr | HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry |
title_full_unstemmed | HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry |
title_short | HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry |
title_sort | hla and autoantibodies define scleroderma subtypes and risk in african and european americans and suggest a role for molecular mimicry |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955366/ https://www.ncbi.nlm.nih.gov/pubmed/31871193 http://dx.doi.org/10.1073/pnas.1906593116 |
work_keys_str_mv | AT gourhpravitt hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT safransaraha hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT alexandertheresa hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT boydenstevene hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT morgannadiad hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT shahamia hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT mayesmaureend hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT doumateyayo hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT bentleyamyr hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT shrinerdaniel hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT domsicrobynt hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT medsgerthomasa hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT ramospaulas hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT silverrichardm hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT steenvirginiad hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT vargajohn hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT hsuvivien hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT saketkoolesleyann hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT schiopuelena hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT khannadinesh hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT gordonjessicak hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT kronbrynn hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT criswelllindseya hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT gladueheather hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT derkchrist hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT bernsteinelanaj hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT bridgesslouis hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT shanmugamvictoriak hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT kolstadkathleend hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT chunglorinda hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT kafajasuzanne hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT janreem hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT trojanowskimarcin hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT goldbergavram hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT kormanbenjamind hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT steinbachpeterj hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT chandrasekharappasettarac hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT mullikinjamesc hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT adeyemoadebowale hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT rotimicharles hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT wigleyfredrickm hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT kastnerdaniell hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT boinfrancesco hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry AT remmerselainef hlaandautoantibodiesdefinesclerodermasubtypesandriskinafricanandeuropeanamericansandsuggestaroleformolecularmimicry |